Patents by Inventor Wenwei Zhang

Wenwei Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11074487
    Abstract: Printers capable of determining a media type of a media and associated methods are provided. An example method includes scanning a media with a verifier associated with the printer to generate at least two consecutive windows of the media. The example method further includes determining a vertical length of a captured image based on a comparison of image characteristic values captured in the at least two consecutive windows. The example method further includes determining a media characteristic associated with the media based at least on the captured image and the vertical length and one or more stored media profiles. The example method further includes calibrating the printer based on the media characteristic.
    Type: Grant
    Filed: February 17, 2020
    Date of Patent: July 27, 2021
    Assignee: DATAMAX-O'NEIL CORPORATION
    Inventors: Heng Yew Lim, Ying Cao, Phek Thong Lee, Cheng Khoon Ng, WenWei Zhang
  • Publication number: 20210214783
    Abstract: A method for constructing a sequencing library, a sequencing library and a sequencing method.
    Type: Application
    Filed: March 25, 2021
    Publication date: July 15, 2021
    Inventors: Luman CUI, Fei FAN, Wenwei ZHANG, Zhou LONG, Weimao WANG, Ou WANG
  • Publication number: 20210172009
    Abstract: Provided are a hooked probe, a method for ligating a nucleic acid and a method for constructing a sequencing library. The hooked probe comprises a target specific area and a hooked area ligated thereto; the target specific area comprises a sequence complementarily paired with at least part of the single chain of the nucleic acid fragment to be ligated; the hooked area comprises a sequence unpaired with the nucleic acid fragment; the end of the hooked area is a ligatable end; and the ligatable end can ligate the end of the single chain of the nucleic acid fragment.
    Type: Application
    Filed: November 9, 2017
    Publication date: June 10, 2021
    Applicant: MGI TECH CO., LTD.
    Inventors: Yuan JIANG, Yang XI, Wenwei ZHANG, Pengjuan LIU, Xia ZHAO, Qiaoling LI, Hanjie SHEN, Yongwei ZHANG, Radoje DRMANAC
  • Publication number: 20210164042
    Abstract: Provided are an adaptor element in a bubble shape, a method of constructing a sequencing library with such an adapter element. The adaptor element is a hybrid formed with a long-chain nucleic acid A and a short-chain nucleic acid B. The hybrid is in the bubble shape with paired regions at two terminals and a non-paired region in the middle.
    Type: Application
    Filed: February 10, 2021
    Publication date: June 3, 2021
    Inventors: Yuan Jiang, Xia Zhao, Qiaoling Li, Shengmao Liu, Bo Wang, Li Chen, Wenwei Zhang, Hui Jiang, Radoje Drmanac
  • Patent number: 10995367
    Abstract: Provided are a vesicular adaptor and a single-chain cyclic library constructed by using the adaptor. The library can be used for RNA sequencing and other sequencing platforms dependent on a single-stranded cyclic library, and has the advantage of high throughput sequencing, high accuracy and simple operations.
    Type: Grant
    Filed: September 19, 2019
    Date of Patent: May 4, 2021
    Assignee: MGI TECH CO., LTD.
    Inventors: Yuan Jiang, Jing Guo, Xiaojun Ji, Chunyu Geng, Kai Tian, Xia Zhao, Huaiqian Xu, Wenwei Zhang, Hui Jiang, Radoje Drmanac
  • Patent number: 10961519
    Abstract: Provided are a phi29 DNA polymerase mutant with increased thermo stability, a method for preparing the mutant, the use of the mutant, and a method for increasing the stability of the phi29 DNA polymerase.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: March 30, 2021
    Assignee: MGI TECH CO., LTD.
    Inventors: Huanhuan Liu, Yue Zheng, Yujun Zhou, Xi Zhang, Zhougang Zhang, Yuliang Dong, Wenwei Zhang, Chongjun Xu, Snezana Drmanac
  • Patent number: 10954559
    Abstract: Provided are an adaptor element in a bubble shape, a method of constructing a sequencing library with such an adapter element. The adaptor element is a hybrid formed with a long-chain nucleic acid A and a short-chain nucleic acid B. The hybrid is in the bubble shape with paired regions at two terminals and a non-paired region in the middle.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: March 23, 2021
    Assignee: MGI TECH CO., LTD.
    Inventors: Yuan Jiang, Xia Zhao, Qiaoling Li, Shengmao Liu, Bo Wang, Li Chen, Wenwei Zhang, Hui Jiang, Radoje Drmanac
  • Patent number: 10883091
    Abstract: Disclosed in the present disclosure is a recombinant DNA polymerase. The recombinant DNA polymerase is any one selected from: A) a protein, having amino acid modifications at positions 408, 409 and 485, and at least one of amino acid modification(s) at positions 53, 59, 199, 243, 526, 558, 613, 641, 671, 673, 674, 692 and 709 compared to the amino acid sequence of a wild-type KOD DNA polymerase; B) a protein derived from the protein in A), formed by deleting amino acids 1 to 29 from a C-terminus of the protein in A) and keeping the remaining amino acids unchanged; and C) a protein derived from the protein in A) or B), formed by connecting a tag to the N-terminus or C-terminus of the amino acid sequence of the protein in A) or B), wherein the protein in A), B) and C) has DNA polymerase activity.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: January 5, 2021
    Assignee: MGI TECH CO., LTD.
    Inventors: Lin Wang, Fen Liu, Yuliang Dong, Wenwei Zhang, Chongjun Xu, Snezana Drmanac
  • Patent number: 10883092
    Abstract: Provided are a phi29 DNA polymerase and an encoding gene and an application thereof. The phi29 DNA polymerase is C1) or C2): C1) is a protein with DNA polymerase activity obtained by substituting at least one of the 58th, 61st, 94th, 96th, 119th, and 155th amino acid residues in the amino acid sequence of a wild type phi29 DNA polymerase as shown in SEQ ID NO: 2 in the sequence listing; and C2) is a fusion protein obtained by linking a label to the N-terminus and/or C-terminus of the protein represented by C1). A 3?-5?exonuclease of the phi29 DNA polymerase has activity lower than that of the wild type phi29 DNA polymerase, and can efficiently and continuously synthesize DNA during amplification and sequencing.
    Type: Grant
    Filed: April 18, 2017
    Date of Patent: January 5, 2021
    Assignee: MGI TECH CO., LTD.
    Inventors: Yue Zheng, Zhougang Zhang, Yuliang Dong, Wenwei Zhang, Chongjun Xu, Snezana Drmanac
  • Publication number: 20200318177
    Abstract: The present invention provides a method for sequencing a nucleic acid using an immersion reaction protocol. The immersion reaction protocol comprises sequentially immersing a solid support having nucleic acid molecules immobilized thereon in different reaction containers to realize nucleic acid sequencing.
    Type: Application
    Filed: August 1, 2017
    Publication date: October 8, 2020
    Inventors: Jin YANG, Xun XU, Hui WANG, Bin XIE, Zhuokun LI, Shengming ZHAO, Ao CHEN, Chongjun XU, Wenwei ZHANG, Ming NI
  • Publication number: 20200318181
    Abstract: Disclosed is a method for obtaining a single-cell mRNA sequence. The method of the present invention comprises: (1) capturing mRNA of a cell by using a cell tag carrier, and performing reverse transcription to obtain cDNA having a cell tag, cDNAs from the same cell having the same cell tag, and cDNAs from different cells having different cell tags; (2) obtaining multiple cDNA fragments having molecular tags by using a transposase complex and a molecular tag carrier, the fragments from the same cDNA having the same molecular tag, and the fragments from different cDNAs having different molecular tags; (3) performing high-throughput sequencing; (4) performing sequence assembly according to the molecular tags to obtain the sequence of each mRNA; and obtaining the sequence of all mRNAs of each single cell according to the cell tags. The method provided by the present invention can be used for obtaining the sequence of all mRNAs of each of a large number of single cells by means of high throughput.
    Type: Application
    Filed: June 23, 2020
    Publication date: October 8, 2020
    Inventors: Fei Fan, Xiaofang Cheng, Wenwei Zhang, Weimao Wang, Luman Cui, Ou Wang
  • Publication number: 20200277673
    Abstract: A nucleic acid probe and a nucleic acid sequencing method for performing sequencing while ligating nucleic acids. The nucleic acid probe is a DNA sequencing probe, comprising a first moiety, a second moiety, a linker, and a detectable label. A base of the first moiety is A, T, U, C, or G, a base of the second moiety is a random base and/or a universal base, and 3 bases or more are present in the second moiety. The first moiety and the second moiety are ligated via the linker, the connection between the first moiety and the ligation can be cleaved, and the detectable label is ligated to the second moiety or the linker. The above probe, a combination formed therewith, or a sequencing method using the same can reduce the number or types of probes in nucleic acid sequencing, thereby reducing cost.
    Type: Application
    Filed: July 6, 2018
    Publication date: September 3, 2020
    Inventors: Erkai LIU, Wenwei ZHANG, Ao CHEN, Chongjun XU
  • Publication number: 20200255821
    Abstract: The present invention provides a method for improving the loading of nucleic acid on a solid support by contacting the solid support with a poloxamer-containing reagent. The present invention also provides a method for improving the stability of a nucleic acid on a solid support, comprising contacting a nucleic acid molecule with a partially double-strand oligonucleotide before or after loading the nucleic acid molecule on a solid support, so as to cause the nucleic acid molecule to hybridize with the oligonucleotide. The present invention also provides a combined use of the two methods.
    Type: Application
    Filed: October 11, 2017
    Publication date: August 13, 2020
    Inventors: Hui WANG, Xun XU, Jin YANG, Ao CHEN, Chongjun XU, Wenwei ZHANG
  • Publication number: 20200208126
    Abstract: Provided are a group of phi29 DNA polymerase mutants having increased thermal stability and use thereof. The phi29 DNA polymerase mutants are proteins obtained by performing point mutation A and/or point mutation B and/or point mutation C on phi29 DNA polymerase, the point mutation A meaning that an amino acid residue M at position 97 of the phi29 DNA polymerase is mutated to other amino acid residue, the point mutation B meaning that an amino acid residue L at position 123 of the phi29 DNA polymerase is mutated into other amino acid residue, and the point mutation C meaning that an amino acid residue E at position 515 of the phi29 DNA polymerase is mutated to other amino acid residue. The stability of the phi29 DNA polymerase mutants is higher than that of a wild-type phi29 DNA polymerase.
    Type: Application
    Filed: August 9, 2017
    Publication date: July 2, 2020
    Inventors: Zhougang Zhang, Huanhuan Liu, Yue Zheng, Yujun Zhou, Xing Liu, Yuliang Dong, Chongjun Xu, Wenwei Zhang
  • Patent number: 10626455
    Abstract: Improved single molecule sequencing methods, compositions, and devices, are provided. In a first aspect, the present invention provides a multi-pass method of sequencing a target sequence using nanopore sequencing, the method comprising: i) providing a non-naturally occurring concatemer nucleic acid molecule comprising a plurality of copies of the target sequence; ii) nanopore sequencing at least three copies of the target sequence in the concatemer, thereby obtaining a multi-pass sequence dataset, wherein the multi-pass sequence dataset comprises target sequence datasets for the at least three copies of the target sequence; and iii) using the multi-pass sequence dataset to determine the target sequence.
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: April 21, 2020
    Assignees: BGI Shenzhen, BGI Shenzhen Co., Ltd.
    Inventors: Handong Li, Y. Tom Tang, Jing Yu, Hui Jiang, Wenwei Zhang, Guangyi Fan, He Zhang, Kailong Ma, Chunyu Geng
  • Publication number: 20200115686
    Abstract: Provided are a phi29 DNA polymerase mutant with increased thermo stability, a method for preparing the mutant, the use of the mutant, and a method for increasing the stability of the phi29 DNA polymerase.
    Type: Application
    Filed: October 18, 2019
    Publication date: April 16, 2020
    Inventors: Huanhuan Liu, Yue Zheng, Yujun Zhou, Xi Zhang, Zhougang Zhang, Yuliang Dong, Wenwei Zhang, Chongjun Xu, Snezana Drmanac
  • Publication number: 20200080140
    Abstract: Provided are a vesicular adaptor and a single-chain cyclic library constructed by using the adaptor. The library can be used for RNA sequencing and other sequencing platforms dependent on a single-stranded cyclic library, and has the advantage of high throughput sequencing, high accuracy and simple operations.
    Type: Application
    Filed: September 19, 2019
    Publication date: March 12, 2020
    Inventors: Yuan Jiang, Jing Guo, Xiaojun Ji, Chunyu Geng, Kai Tian, Xia Zhao, Huaiqian Xu, Wenwei Zhang, Hui Jiang, Radoje Drmanac
  • Patent number: 10563196
    Abstract: The present invention provides a primer for nucleic acid random fragmentation and a nucleic acid random fragmentation method. The primer consists of a plurality of upstream random primers and downstream random primers. The sequence composition of the upstream random primers is 5?-X-Y-3?, and the sequence composition of the downstream random primers is 5?-P-Y?-X?-close-3?, wherein Y and Y? are random sequences, X is all or part of sequences of a sequencing platform 5? end adaptor, X? is all or part of sequences of a sequencing platform 3? end adaptor, P is phosphorylation modification, and close is close modification. The primer of the present invention adopts double random anchoring of both the upstream random primers and the downstream random primers, and a DNA sample can be randomly broken.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: February 18, 2020
    Assignee: MGI TECH CO., LTD
    Inventors: Chunyu Geng, Hongyan Han, Guangying Guo, Wenwei Zhang, Hui Jiang, Yuan Jiang
  • Publication number: 20200048620
    Abstract: Provided are a phi29 DNA polymerase and an encoding gene and an application thereof. The phi29 DNA polymerase is C1) or C2): C1) is a protein with DNA polymerase activity obtained by substituting at least one of the 58th, 61st, 94th, 96th, 119th, and 155th amino acid residues in the amino acid sequence of a wild type phi29 DNA polymerase as shown in SEQ ID NO: 2 in the sequence listing; and C2) is a fusion protein obtained by linking a label to the N-terminus and/or C-terminus of the protein represented by C1). A 3?-5?exonuclease of the phi29 DNA polymerase has activity lower than that of the wild type phi29 DNA polymerase, and can efficiently and continuously synthesize DNA during amplification and sequencing.
    Type: Application
    Filed: April 18, 2017
    Publication date: February 13, 2020
    Inventors: Yue ZHENG, Zhougang ZHANG, Yuliang DONG, Wenwei ZHANG, Chongjun XU, Snezana DRMANAC
  • Patent number: 10544451
    Abstract: Provided are a vesicular linker and a single-chain cyclic library constructed by using the linker. The library can be used for RNA sequencing and other sequencing platforms dependent on a single-stranded cyclic library, and has the advantages of high throughput sequencing, high accuracy and simple operations.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: January 28, 2020
    Assignee: MGI TECH CO., LTD.
    Inventors: Yuan Jiang, Jing Guo, Xiaojun Ji, Chunyu Geng, Kai Tian, Xia Zhao, Huaiqian Xu, Wenwei Zhang, Hui Jiang, Radoje Drmanac